[go: up one dir, main page]

GB202308304D0 - A fusion peptide for activation of the apj and/or glp-1 receptors - Google Patents

A fusion peptide for activation of the apj and/or glp-1 receptors

Info

Publication number
GB202308304D0
GB202308304D0 GBGB2308304.1A GB202308304A GB202308304D0 GB 202308304 D0 GB202308304 D0 GB 202308304D0 GB 202308304 A GB202308304 A GB 202308304A GB 202308304 D0 GB202308304 D0 GB 202308304D0
Authority
GB
United Kingdom
Prior art keywords
apj
glp
receptors
activation
fusion peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2308304.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ulster University
Original Assignee
Ulster University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulster University filed Critical Ulster University
Priority to GBGB2308304.1A priority Critical patent/GB202308304D0/en
Publication of GB202308304D0 publication Critical patent/GB202308304D0/en
Priority to PCT/EP2024/064554 priority patent/WO2024246015A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB2308304.1A 2023-06-02 2023-06-02 A fusion peptide for activation of the apj and/or glp-1 receptors Ceased GB202308304D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2308304.1A GB202308304D0 (en) 2023-06-02 2023-06-02 A fusion peptide for activation of the apj and/or glp-1 receptors
PCT/EP2024/064554 WO2024246015A1 (en) 2023-06-02 2024-05-27 A fusion peptide for activation of the apj and / or glp-1 receptors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2308304.1A GB202308304D0 (en) 2023-06-02 2023-06-02 A fusion peptide for activation of the apj and/or glp-1 receptors

Publications (1)

Publication Number Publication Date
GB202308304D0 true GB202308304D0 (en) 2023-07-19

Family

ID=87157009

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2308304.1A Ceased GB202308304D0 (en) 2023-06-02 2023-06-02 A fusion peptide for activation of the apj and/or glp-1 receptors

Country Status (2)

Country Link
GB (1) GB202308304D0 (en)
WO (1) WO2024246015A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506724B1 (en) 1999-06-01 2003-01-14 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
EP1076066A1 (en) 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels
TW201138808A (en) 2010-05-03 2011-11-16 Bristol Myers Squibb Co Serum albumin binding molecules
MX2014005351A (en) * 2011-11-03 2014-05-28 Zealand Pharma As Glp-1 receptor agonist peptide gastrin conjugates.
AP2016009019A0 (en) 2013-07-25 2016-02-29 Novartis Ag Bioconjugates of synthetic apelin polypeptides
ES2805743T3 (en) 2015-03-24 2021-02-15 Inst Nat Sante Rech Med Method and pharmaceutical composition for use in the treatment of diabetes
CN117510646A (en) * 2022-08-03 2024-02-06 无锡市华盛康肽生物技术有限公司 Dual-function fusion protein and application thereof

Also Published As

Publication number Publication date
WO2024246015A1 (en) 2024-12-05

Similar Documents

Publication Publication Date Title
PL3989972T3 (en) Glucagon-like peptide 1 receptor agonists
IL289887A (en) Fusion polypeptide for immunotherapy
IL288143A (en) Natriuretic peptide receptor 1 antibodies and methods of use
SG11202105586YA (en) Modified gip peptide analogues
IL189420A0 (en) Method for the recombinant expression of a polypeptid
IL308397A (en) Macrocyclic glucagon-like peptide 1 receptor agonists
EP3744465A4 (en) Arc welding method for dissimilar material bonding
IL278197A (en) Glucagon like peptide 1 (glp-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
GB202308304D0 (en) A fusion peptide for activation of the apj and/or glp-1 receptors
GB202113559D0 (en) Fusion polypeptide
PL3715105T3 (en) Laminated material for forming a flexible container and flexible tube skirt comprising said laminated material
DK3498291T3 (en) Pharmaceutical composition and biomaterial comprising a parathyroid hormone (PTH) fusion peptide conjugated with a bone tissue-selective peptide
SG11202107147WA (en) Adhesion promoter for piezoceramic hydrophone
GB201903373D0 (en) Method of forming a diffusion bonded joint
GB202307936D0 (en) Fusion protein
GB202307932D0 (en) Fusion protein
IL315354A (en) Insulin fusion protein
GB202219551D0 (en) Peptide fusion
EP4010008A4 (en) Elp fusion proteins comprising parathyroid hormone for controlled and sustained release
EP4423260A4 (en) Truncated and fusion proteins
IL325586A (en) Fusion polypeptide aj007 and use thereof
GB201903132D0 (en) A peptide for the delivery of anionic materials
EP4161944A4 (en) A fusion protein
GB202105044D0 (en) Fusion protein
HK40062412A (en) Natriuretic peptide receptor 1 antibodies and methods of use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)